Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Tadalafil USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Tadalafil USP (Monohydrate) for prescription compounding, packaged in a) 5g (NDC 58597-8538-2); b) 25g (NDC 58597-8538-4); c)100g (NDC 58597-8538-6); d) 500g (NDC 58597-8538-7); d) 1000g (NDC 58597-8538-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Affected NDCs 58597-8538-02 58597-8538-04 58597-8538-06 58597-8538-07 58597-8538-08

Compare with the code on your package — it is the most precise check available.

Drug: Tadalafil

Recalling firm
American Pharmaceutical Ingredients LLC
NDC code
58597-8538-2
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0524-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Tadalafil recalls

See all
Class II · Moderate risk

Tadalafil USP

CGMP Deviations:Noted during FDA inspection

Ongoing cGMP deviation Shoolin Pharma Chem LLP NDC 85702-001-08 D-0762-2026
Class II · Moderate risk

Tadalafil USP

CGMP Deviations:Noted during FDA inspection

Ongoing cGMP deviation Shoolin Pharma Chem LLP NDC 85702-002-04 D-0761-2026
Class II · Moderate risk

Tadalafil USP

CGMP Deviations:Noted during FDA inspection

Ongoing cGMP deviation Shoolin Pharma Chem LLP NDC 85702-002-02 D-0760-2026
Class II · Moderate risk

Tadalafil Tablets

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Ongoing cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-8153-7 D-0526-2023

Other recalls by American Pharmaceutical Ingredients LLC

All 2018 recalls
Class II · Moderate risk

Sermorelin Acetate

Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8092-1 D-0592-2018
Class II · Moderate risk

Oxytocin USP

Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-7042-3 D-0591-2018
Class II · Moderate risk

Fluticasone propionate USP

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8276-3 D-0539-2018
Class II · Moderate risk

Cyanocobalamin USP

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8044-1 D-0538-2018